Research ArticleDrug Discovery and Translational Medicine
Pharmaceutical Characterization of Tropomyosin Receptor Kinase B-Agonistic Antibodies on Human Induced Pluripotent Stem (hiPS) Cell–Derived Neurons
Stefanie Traub, Heiko Stahl, Holger Rosenbrock, Eric Simon, Lore Florin, Lisa Hospach, Stefan Hörer and Ralf Heilker
Journal of Pharmacology and Experimental Therapeutics June 2017, 361 (3) 355-365; DOI: https://doi.org/10.1124/jpet.117.240184
Stefanie Traub
Trenzyme GmbH, Konstanz (S.T.) Germany, Lead Identification and Optimization Support (L.H., S.H., R.H.), Immunological and Respiratory Diseases Research (H.S.), CNS Diseases Research (H.R.), and Target Discovery Research (E.S.), Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut (L.F.)
Heiko Stahl
Trenzyme GmbH, Konstanz (S.T.) Germany, Lead Identification and Optimization Support (L.H., S.H., R.H.), Immunological and Respiratory Diseases Research (H.S.), CNS Diseases Research (H.R.), and Target Discovery Research (E.S.), Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut (L.F.)
Holger Rosenbrock
Trenzyme GmbH, Konstanz (S.T.) Germany, Lead Identification and Optimization Support (L.H., S.H., R.H.), Immunological and Respiratory Diseases Research (H.S.), CNS Diseases Research (H.R.), and Target Discovery Research (E.S.), Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut (L.F.)
Eric Simon
Trenzyme GmbH, Konstanz (S.T.) Germany, Lead Identification and Optimization Support (L.H., S.H., R.H.), Immunological and Respiratory Diseases Research (H.S.), CNS Diseases Research (H.R.), and Target Discovery Research (E.S.), Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut (L.F.)
Lore Florin
Trenzyme GmbH, Konstanz (S.T.) Germany, Lead Identification and Optimization Support (L.H., S.H., R.H.), Immunological and Respiratory Diseases Research (H.S.), CNS Diseases Research (H.R.), and Target Discovery Research (E.S.), Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut (L.F.)
Lisa Hospach
Trenzyme GmbH, Konstanz (S.T.) Germany, Lead Identification and Optimization Support (L.H., S.H., R.H.), Immunological and Respiratory Diseases Research (H.S.), CNS Diseases Research (H.R.), and Target Discovery Research (E.S.), Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut (L.F.)
Stefan Hörer
Trenzyme GmbH, Konstanz (S.T.) Germany, Lead Identification and Optimization Support (L.H., S.H., R.H.), Immunological and Respiratory Diseases Research (H.S.), CNS Diseases Research (H.R.), and Target Discovery Research (E.S.), Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut (L.F.)
Ralf Heilker
Trenzyme GmbH, Konstanz (S.T.) Germany, Lead Identification and Optimization Support (L.H., S.H., R.H.), Immunological and Respiratory Diseases Research (H.S.), CNS Diseases Research (H.R.), and Target Discovery Research (E.S.), Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut (L.F.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleDrug Discovery and Translational Medicine
TrkB-Agonistic Antibodies on Human iPS Cell-Derived Neurons
Stefanie Traub, Heiko Stahl, Holger Rosenbrock, Eric Simon, Lore Florin, Lisa Hospach, Stefan Hörer and Ralf Heilker
Journal of Pharmacology and Experimental Therapeutics June 1, 2017, 361 (3) 355-365; DOI: https://doi.org/10.1124/jpet.117.240184
Research ArticleDrug Discovery and Translational Medicine
TrkB-Agonistic Antibodies on Human iPS Cell-Derived Neurons
Stefanie Traub, Heiko Stahl, Holger Rosenbrock, Eric Simon, Lore Florin, Lisa Hospach, Stefan Hörer and Ralf Heilker
Journal of Pharmacology and Experimental Therapeutics June 1, 2017, 361 (3) 355-365; DOI: https://doi.org/10.1124/jpet.117.240184
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement